Search results
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 days agoThe company's flagship product, Cologuard, is the first FDA-approved non-invasive stool-based DNA ...
Tricare Lowers Age for Colon Cancer Screenings to 45
Military.com· 2 weeks agoTricare beneficiaries at average risk for colorectal cancer can now receive covered screening exams and lab tests five years sooner, at age 45, following...
A blood test to help detect lung cancer? New test offered at OSF Healthcare part of trend in...
Chicago Tribune via Yahoo News· 1 day agoCHICAGO — Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only...
New Day Aims to Enter CRC Screening Market With Combined PCR, Immunoassay Test
GenomeWeb News· 6 days agoEDP had developed prior to the deal a multiplex immunoassay, ColoPlex, for the early detection of colorectal cancer and precancerous polyps. Later that month, New Day said ...
Geneoscopy Nabs FDA Approval for Stool-Based Colorectal Cancer Screening Test
GenomeWeb News· 5 days agoOncology diagnostics firm Geneoscopy said Tuesday that the US Food and Drug Administration has approved its noninvasive, stool-based colorectal cancer screening< ...
It may be safe for some to wait 15 years for repeat colonoscopy, study suggests
NBC News via Yahoo News· 1 week agoNew research suggests average-risk patients may only need to get a colonoscopy for colorectal cancer...
Exact Sciences (NASDAQ:EXAS) Hits New 12-Month Low on Analyst Downgrade
ETF DAILY NEWS· 1 day agoExact Sciences Co. (NASDAQ:EXAS – Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday after Canaccord Genuity Group lowered their price target on the stock from ...
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by California Public Employees Retirement System
ETF DAILY NEWS· 2 weeks agoCalifornia Public Employees Retirement System lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.0% in the fourth quarter, according to the company in its ...
Van ECK Associates Corp Sells 9,078 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 1 week agoVan ECK Associates Corp trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.1% in the 4th quarter, according to the company in its most recent Form 13F filing ...